This article explores how advances in AI, structural biology, and new drug modalities are transforming “undruggable” proteins ...
Precision bacteriophages reduced gut inflammation by blocking harmful bacterial activity, while boosting the effects of a ...
Many cancer-associated mutational signatures remain unexplained. Team CAUSE aims to connect DNA damage, mutational patterns, ...
A streamlined gene editing platform enables tissue-wide CRISPR screening in human organoids, identifying genes that regulate ...
Researchers tested KCL-286 in Alzheimer’s models, finding it reduced DNA damage and inflammation. The drug targets retinoic ...
Using a genome-wide CRISPR screen and AI analysis, researchers uncovered unexpected psoriasis drug targets, including the ...
This listicle examines the technical foundations, readiness levels, and performance trade-offs shaping the future battery ...
ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...
A mathematical model showed that chemotaxis drives hair follicle formation in different mammals, suggesting that simple cell ...
As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke ...
An AI approach has been developed that accurately predicts how quickly drug-delivery materials release therapies, potentially ...
Artificial intelligence (AI) in research histopathology is turning whole-slide images of preclinical tissue into structured, quantitative data rather than a pathologist's subjective impression alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results